A novel allele, HLA-C*15:227, identified when typing COVID-19 patients.


Journal

HLA
ISSN: 2059-2310
Titre abrégé: HLA
Pays: England
ID NLM: 101675570

Informations de publication

Date de publication:
04 2021
Historique:
revised: 27 01 2021
received: 11 01 2021
accepted: 30 01 2021
pubmed: 5 2 2021
medline: 26 3 2021
entrez: 4 2 2021
Statut: ppublish

Résumé

HLA-C*15:227 differs from HLA-C*15:02:01:01 by a single nonsynonymous change (368A → G Tyrosine 99 to Cysteine).

Identifiants

pubmed: 33539638
doi: 10.1111/tan.14199
pmc: PMC8013338
doi:

Substances chimiques

HLA-C Antigens 0
HLA-C*15 antigen 0

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

377-378

Subventions

Organisme : Ministry of Science and Higher Education of the Russian Federation
ID : 075-15-2019-1789

Informations de copyright

© 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

Tissue Antigens. 2010 Apr;75(4):291-455
pubmed: 20356336
Nucleic Acids Res. 2020 Jan 8;48(D1):D948-D955
pubmed: 31667505
HLA. 2021 Apr;97(4):377-378
pubmed: 33539638

Auteurs

Valery Cheranev (V)

Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Pirogov Medical University, Moscow, Russia.

Maria Loginova (M)

The Research Laboratory of Applied Immunogenetics, Federal State Budget Research Institution: Kirov Hematology and Blood Transfusion Research Institute under the Federal Medicine and Biology Agency, Kirov, Russia.

Tatjana Jankevic (T)

Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Pirogov Medical University, Moscow, Russia.

Svetlana Kutyavina (S)

The Research Laboratory of Applied Immunogenetics, Federal State Budget Research Institution: Kirov Hematology and Blood Transfusion Research Institute under the Federal Medicine and Biology Agency, Kirov, Russia.

Denis Rebrikov (D)

Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Pirogov Medical University, Moscow, Russia.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH